Skip to main content

Diagnostic options ยท UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00โ€“150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 706โ€“720 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3152
Spinal Muscular Atrophy (SMA) Carrier Detection Test

This test evaluates an individual's carrier status for Spinal Muscular Atrophy (SMA) by analyzing the SMN1 gene.

Whole blood (EDTA lavender top) 5 business days (sample collected Monday by 11 AM, report by Saturday) 2,000.00 AED
View
View test specifications and preparation
What it measures
["SMN1 exon 7 copy number", "SMN1 exon 8 copy number"]
Parameters
[{"name": "SMN1 Exon 7 Copy Number", "reference_range": "2 copies (Normal)"}, {"name": "SMN1 Exon 8 Copy Number", "reference_range": "2 copies (Normal)"}]
Preparation
["No dietary or drug restrictions are required", "Inform phlebotomist about any anticoagulants"]
Indications
["Family history of spinal muscular atrophy", "Couples planning pregnancy", "Premarital screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21671-0 ICD-10: Z13.89, Z31.5
Clinical summary
This test evaluates an individual's carrier status for Spinal Muscular Atrophy (SMA) by analyzing the SMN1 gene.
TEST-3159
Spinal Muscular Atrophy (SMA) Mutation Detection Test

This test detects deletions and copy number variations in the SMN1 gene, the primary cause of Spinal Muscular Atrophy (SMA). It is used for diagnosis and carrier screening.

Peripheral Whole Blood (Lavender-top EDTA Tube) 6 business days (sample submission Monday by 11 AM โ†’ report Saturday) 2,000.00 AED
View
View test specifications and preparation
What it measures
["SMN1 gene deletions", "SMN1 gene copy number variations"]
Parameters
[]
Preparation
["No fasting required", "Complete Genomics Clinical Information Requisition Form (Form 20)"]
Indications
["Clinical suspicion of SMA", "Family history of SMA", "Carrier screening for at-risk couples", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 36911-9 ICD-10: G12.9, G12.0, G12.1
Clinical summary
This test detects deletions and copy number variations in the SMN1 gene, the primary cause of Spinal Muscular Atrophy (SMA). It is used for diagnosis and carrier screening.
TEST-3085
Spinocerebellar Ataxia (SCA) Comprehensive Profile Test

This test evaluates for pathogenic trinucleotide repeat expansions and mutations in genes linked to multiple types of Spinocerebellar Ataxia (SCA) and DRPLA.

Peripheral whole blood 5โ€“7 business days from sample receipt 1,800.00 AED
View
View test specifications and preparation
What it measures
["Trinucleotide repeat expansions", "Mutations in SCA-associated genes"]
Parameters
[]
Preparation
["No fasting required", "Complete Genomics Clinical Information Requisition Form", "Inform collection team if on blood-thinning medication"]
Indications
["Suspected hereditary ataxia", "Differential diagnosis of ataxia", "Family screening for SCA carriers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81320-0 ICD-10: G11.9
Clinical summary
This test evaluates for pathogenic trinucleotide repeat expansions and mutations in genes linked to multiple types of Spinocerebellar Ataxia (SCA) and DRPLA.
TEST-3058
Spinocerebellar Ataxia (SCA) Extended Profile Test

This genetic test identifies pathogenic trinucleotide repeat expansions in multiple genes associated with Spinocerebellar Ataxia (SCA). It provides a definitive molecular diagnosis...

4 mL EDTA Whole Blood (Lavender-top tube) 5 working days 4,500.00 AED
View
View test specifications and preparation
What it measures
["Trinucleotide repeat expansions", "Pathogenic mutations in SCA genes (SCA1, 2, 3, 6, 7, 8, 10, 12, 17, DRPLA)"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Suspected hereditary ataxia", "Differential diagnosis of ataxia syndromes", "Genetic counseling for families with ataxia", "Prognosis determination"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94308-8 ICD-10: G11.8, G11.1, G11.2
Clinical summary
This genetic test identifies pathogenic trinucleotide repeat expansions in multiple genes associated with Spinocerebellar Ataxia (SCA). It provides a definitive molecular diagnosis for hereditary ataxia.
TEST-3054
Spinocerebellar Ataxia (SCA) Genetic Profile (4 Markers) Test

This test identifies pathogenic trinucleotide repeat expansions in the SCA1, SCA2, SCA3, and SCA6 genes, which are common causes of autosomal dominant cerebellar ataxia.

Peripheral Whole Blood (EDTA) Report by Saturday (sample received by Tuesday 11:00 AM) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Trinucleotide repeat expansions in SCA1 gene", "Trinucleotide repeat expansions in SCA2 gene", "Trinucleotide repeat expansions in SCA3 gene", "Trinucleotide repeat expansions in SCA6 gene"]
Parameters
[]
Preparation
["No fasting required", "No special dietary preparation needed", "Ensure Genomics Clinical Information Requisition Form (Form 20) is completed and signed"]
Indications
["Clinical suspicion of hereditary ataxia", "Family history suggestive of autosomal dominant ataxia", "Need for definitive diagnosis to guide management and counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94249-3 ICD-10: G11.9, G11.8
Clinical summary
This test identifies pathogenic trinucleotide repeat expansions in the SCA1, SCA2, SCA3, and SCA6 genes, which are common causes of autosomal dominant cerebellar ataxia.
TEST-1102
Spinocerebellar Ataxia (SCA) Test

This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) in a peripheral blood sample.

Peripheral whole blood (EDTA tube) 5โ€“7 working days 700.00 AED
View
View test specifications and preparation
What it measures
["Specific SCA gene mutation", "Pathogenic variant detection"]
Parameters
[]
Preparation
[]
Indications
["Clinical symptoms suggestive of SCA", "Family history of SCA", "Suspected specific SCA subtype"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34777-8 ICD-10: G11.9
Clinical summary
This test identifies specific genetic mutations associated with Spinocerebellar Ataxia (SCA) in a peripheral blood sample.
TEST-3194
SPTA1 Gene Spherocytosis Type 3 Genetic Test

This genetic test evaluates the SPTA1 gene for pathogenic variants associated with hereditary spherocytosis type 3.

Peripheral Whole Blood (3-5 mL EDTA) or Buccal Swab 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SPTA1 gene", "Single nucleotide variants", "Indels", "Copy number variations"]
Parameters
[]
Preparation
["No fasting or dietary restrictions are necessary", "Completed clinical questionnaire", "Genetic counseling session with three-generation pedigree", "Signed informed consent"]
Indications
["Clinical suspicion of hereditary spherocytosis type 3", "Identification of asymptomatic carriers", "Guidance for reproductive and clinical management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77608-5 ICD-10: D58.0, Z13.0, Z31.5
Clinical summary
This genetic test evaluates the SPTA1 gene for pathogenic variants associated with hereditary spherocytosis type 3.
TEST-348
Squash/Zucchini GMO Testing Test

This diagnostic test evaluates the presence of genetically modified DNA sequences in squash or zucchini food samples.

Food sample (squash or zucchini) 1 Week 1,000.00 AED
View
View test specifications and preparation
What it measures
["Genetically Modified DNA Sequences"]
Parameters
[]
Preparation
[]
Indications
["Verifying GMO-free labeling", "Ensuring compliance with UAE food safety regulations", "Supporting dietary protocols avoiding genetically engineered foods"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88215-5 ICD-10: Z13.9
Clinical summary
This diagnostic test evaluates the presence of genetically modified DNA sequences in squash or zucchini food samples.
TEST-5353
SRGAP2 Gene Neuronal Migration Disorder Genetic Test

This genetic test evaluates the SRGAP2 gene for variants associated with neuronal migration disorders.

Peripheral whole blood (venous or capillary) or FTA card 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SRGAP2 gene variants", "Single-nucleotide variants (SNVs)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Suspected neuronal migration disorder", "Diagnosis of epilepsy with developmental delay", "Family history of SRGAP2-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81233-7 ICD-10: Q04.8
Clinical summary
This genetic test evaluates the SRGAP2 gene for variants associated with neuronal migration disorders.
TEST-1233
SRY Gene FISH Test (Y Chromosome Microdeletion)

This test detects the presence or absence of the SRY gene on the Y chromosome using Fluorescence In Situ Hybridization (FISH). It is used to investigate disorders of sexual develop...

Peripheral whole blood 4 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Presence of SRY gene", "Y chromosome material"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Disorders of Sexual Development (DSD)", "Turner syndrome mosaicism", "Cryptic Y-chromosome rearrangements"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33776-2 ICD-10: Q98.8
Clinical summary
This test detects the presence or absence of the SRY gene on the Y chromosome using Fluorescence In Situ Hybridization (FISH). It is used to investigate disorders of sexual development and chromosomal abnormalities.
TEST-600
Stachybotrys (RNA Detection) Qualitative Test

This test detects the presence of viable RNA from Stachybotrys chartarum, indicating an active infection.

Tissue, biopsy, respiratory secretions 36-48 hours 700.00 AED
View
View test specifications and preparation
What it measures
["Stachybotrys chartarum RNA", "Presence of active fungal infection"]
Parameters
[]
Preparation
["Signed informed consent required", "Submission of complete clinical history required"]
Indications
["Suspected mold-related illness", "Exposure to water-damaged buildings", "Patients with unexplained respiratory symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88139-6 ICD-10: B49, Z03.818
Clinical summary
This test detects the presence of viable RNA from Stachybotrys chartarum, indicating an active infection.
TEST-1986
SUFU Gene Meningioma Susceptibility Test (NGS)

This test evaluates the SUFU gene for germline variants associated with an increased risk of developing meningiomas.

Peripheral Whole Blood (EDTA) or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SUFU gene coding region variants", "Copy Number Variations (CNVs) in SUFU gene"]
Parameters
[{"name": "SUFU Gene Analysis", "reference_range": "No pathogenic variants detected"}]
Preparation
["Mandatory genetic counselling session prior to sample collection", "Construction of a pedigree chart documenting family members affected with SUFU-gene-associated meningioma"]
Indications
["Individuals with a personal or family history of meningiomas", "Individuals with clinical features suggesting Gorlin syndrome or related hereditary tumour predisposition syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81307-8 ICD-10: Z15.09, Z80.0
Clinical summary
This test evaluates the SUFU gene for germline variants associated with an increased risk of developing meningiomas.
TEST-351
Sugar Beet GMO Detection Test (PCR)

This test detects and quantifies genetically modified sugar beet DNA sequences in whole blood using multiplex Real-Time PCR (qPCR) / Digital Droplet PCR.

Whole Blood (Peripheral Venipuncture) 5โ€“7 Business Days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Genetically modified sugar beet DNA sequences", "Quantification of GMO content in blood"]
Parameters
[]
Preparation
["No special fasting is required."]
Indications
["Investigation of recent exposure to transgenic sugar beet DNA", "Research purposes related to GMO exposure"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80203-9 ICD-10: Z13.89
Clinical summary
This test detects and quantifies genetically modified sugar beet DNA sequences in whole blood using multiplex Real-Time PCR (qPCR) / Digital Droplet PCR.
TEST-61
Tโ€‘Cell Gene Rearrangement Mutation Detection Test

This test identifies clonal expansions of T-cells by detecting unique rearrangements in T-cell receptor genes using multiplex PCR and fragment analysis.

Peripheral whole blood (EDTA) 15 working days 2,500.00 AED
View
View test specifications and preparation
What it measures
["T-cell receptor gene rearrangements (gamma and beta chain)", "Clonality of T-cell populations"]
Parameters
[]
Preparation
[]
Indications
["Suspicion of T-cell lymphoma", "Monitoring for minimal residual disease (MRD) in T-cell lymphoma", "Distinguishing T-cell lymphomas from reactive lymphoproliferative disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31208-2 ICD-10: C84.4, C84.9, Z15.0
Clinical summary
This test identifies clonal expansions of T-cells by detecting unique rearrangements in T-cell receptor genes using multiplex PCR and fragment analysis.
TEST-3207
t(12;21)(p13;q22) ETV6-RUNX1 (TEL-AML1) PCR Qualitative Test

This test detects the ETV6-RUNX1 gene fusion, a key marker for risk stratification in childhood B-cell acute lymphoblastic leukemia.

Bone Marrow Aspirate or EDTA Whole Blood 3 Working Days 650.00 AED
View
View test specifications and preparation
What it measures
["Presence of ETV6-RUNX1 fusion transcript", "t(12;21) chromosomal translocation"]
Parameters
[]
Preparation
["No specific patient preparation required."]
Indications
["Diagnosis of childhood B-cell acute lymphoblastic leukemia (B-ALL)", "Risk stratification in B-ALL", "Monitoring for minimal residual disease (MRD)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60515-4 ICD-10: C91.00
Clinical summary
This test detects the ETV6-RUNX1 gene fusion, a key marker for risk stratification in childhood B-cell acute lymphoblastic leukemia.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area